12/12/2025CMS's NDA for Innovative Stroke Drug Y-3 for Injection Accepted in Ch...

12/12/2025Ascletis' Acne Drug Denifanstat Enters NMPA Review After NDA Acceptanc...

12/12/2025InnoCare Pharma Wins NMPA Approval for Next-Gen TRK Inhibitor Zurletre...

12/11/2025China Approves Sanofi's Qfitlia (fitusiran) for Severe Hemophilia

12/11/2025Forward Pharma Reports Promising Early Data for Oral SERD FWD1802

12/11/2025Hengrui Launches Phase 1/2 Trial of Subcutaneous PD-1/VEGF BsAb SHR-46...

12/11/2025Kelingyuan Reports Early Tumor Responses for Novel HER2-Targeted ADC S...

12/11/2025China Approves Boehringer Ingelheim's Jascayd for Progressive Pulmonar...

12/10/2025Dizal Showcases Broad ASH25 Data for Golidocitinib and Birelentinib

12/10/2025InnoCare Highlights Strong ASH25 Data for BCL2 Inhibitor Mesutoclax

12/10/2025Lepu Reports Encouraging Phase II Results for CD20-Targeted ADC Combo

12/9/2025Ascletis Reports Positive Phase II Results for Oral GLP-1 Agonist ASC3...

12/9/2025Biokin Reports Strong Phase 2 Results for HER2-Targeted ADC T-Bren

12/8/2025Pfizer Files for Approval of Zavegepant Nasal Spray in China

12/8/2025CSPC's Semaglutide Injection Moves Forward — sNDA Accepted, Obesity I...

12/4/2025Lynk Receives FDA IND Approval for Its Brain-Penetrant Allosteric TYK2...

12/1/2025New ADC Shows Broad Antitumor Activity With Strong Bystander Effect

12/1/2025Innovent's Pecondle Wins China Approval as First Homegrown IL-23p19 An...

11/28/2025Gan & Lee Launches GRADUAL-3 Phase 3 Trial of Once-Monthly Bofanglutid...

11/28/2025Zhongmou Reports Strong First-in-Human Results for Optogenetic Gene Th...

11/28/2025BeOne Secures USFDA Priority Review for Sonrotoclax

11/27/2025Novartis's Rhapsido Approved for Chronic Spontaneous Urticaria in Chin...

11/27/2025Ascentage Pharma Publishes Phase Ib Data for Olverembatinib in GIST

11/27/2025NMPA Approves AstraZeneca's Imfinzi for NSCLC in China

11/27/2025Biontech to Present Phase 2 Data for Bispecific Antibody Pumitamig in ...

11/27/2025CSPC's JMT206 Wins Green Light for First-in-Human Trials in China

11/27/2025Sugemalimab Wins European Approval for Stage III NSCLC

11/25/2025Kelun Reports Positive Phase 2 Results for Sac-TMT Combined with KEYTR...

11/25/2025Luye Pharma Receives FDA IND Clearance for LY03017

11/25/2025Huaota Reports Pivotal Phase 3 Success for HB0017

Page:1/20 Total number of articles:595: [First][<<] [1] [2] [3] [4] [5] [>>] [End]